Real-world impact of fremanezumab on migraine-related health care utilization and costs in patients with common comorbidities, acute medication overuse, or difficult-to-treat migraine

被引：0
|
作者：
Buse, D. C. [1 ,2 ]
Driessen, M. T. [3 ]
Krasenbaum, L. J. [4 ]
Seminerio, M. J. [5 ,6 ]
Carr, K. [5 ]
Ortega, M. [5 ]
Packnett, E. R. [7 ]
机构：
[1] Albert Einstein Coll Med, Dept Neurol, New York, NY USA
[2] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA
[3] Teva Pharmaceut, Amsterdam, Netherlands
[4] Teva Branded Pharmaceut Prod R&D Inc, W Chester, PA USA
[5] Teva Pharmaceut, Parsippany, NJ USA
[6] Teva Pharmaceut, W Chester, PA USA
[7] IBM Watson Hlth, Cambridge, MA USA
来源：
HEADACHE | 2022年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-91
引用
收藏
页码：80 / 81
页数：2
相关论文
共 50 条
  • [21] No 'Wearing-Off Effect' Seen with Fremanezumab in the Real-World: Retrospective, Claims-Based Analysis of Migraine-Related Healthcare Resource and Acute Medication Use
    Ailani, Jessica
    Xie, Handing
    Driessen, Maurice
    Ortega, Mario
    Wang, Yitong
    Campos, Verena Ramirez
    Lim, Sangtaeck
    NEUROLOGY, 2023, 100 (17)
  • [22] Real-world assessment of the relationship between migraine-related disability and healthcare costs in the United States
    Harris, Linda
    L'Italien, Gilbert
    Kumar, Anil
    Seelam, Prafullakumar
    LaVallee, Chris
    Coric, Vladimir
    Lipton, Richard B.
    HEADACHE, 2022, 62 (04): : 473 - 481
  • [23] The economic impact of acute medication overuse among patients with migraine or headache: A managed care perspective
    Pesa, J. A.
    Thayer, S.
    Rupnow, M. F.
    Biondi, D.
    Yaldo, A.
    VALUE IN HEALTH, 2008, 11 (03) : A142 - A142
  • [24] Real-world Factors Associated with Acute Medication Overuse in Patients with Migraine: Results From the Medical Expenditure Panel Survey (MEPS)
    Joshi, Shivang
    Ye, Wenyu
    Ford, Janet H.
    Nelson, David R.
    Aurora, Sheena K.
    CEPHALALGIA, 2019, 39 : 186 - 186
  • [25] REAL-WORLD REDUCTIONS IN ACUTE MEDICATION USE FOR PATIENTS WITH MIGRAINE INITIATING FREMANEZUMAB: A 12-MONTH RETROSPECTIVE US CLAIMS ANALYSIS
    Krasenbaum, L. J.
    Driessen, M. T.
    Seminerio, M. J.
    DiEgidio, R.
    Tian, M.
    VALUE IN HEALTH, 2022, 25 (07) : S325 - S325
  • [26] THE IMPACT OF FREMANEZUMAB ON MIGRAINE-SPECIFIC HEALTH-RELATED QUALITY OF LIFE IN CHRONIC MIGRAINE PATIENTS WITH CONCOMITANT PREVENTIVE MEDICATION USE
    Lipton, R. B.
    Fitzgerald, T.
    Cohen, J. M.
    Gandhi, S. K.
    CEPHALALGIA, 2018, 38 : 95 - 96
  • [27] The Impact of Fremanezumab on Migraine-Specific Health-Related Quality of Life in Chronic Migraine Patients With Concomitant Preventive Medication Use
    Gandhi, Sanjay
    Lipton, Richard
    Cohen, Joshua
    NEUROLOGY, 2019, 92 (15)
  • [28] Real-world migraine-related healthcare resource utilization and costs associated with improved vs. worsened/stable migraine: a panel-based chart review in France, Germany, Italy, and Spain
    Vo, Pamela
    Swallow, Elyse
    Wu, Eric
    Zichlin, Miriam L.
    Katcher, Noah
    Maier-Peuschel, Monika
    Naclerio, Mariantonietta
    Ritrovato, Daniela
    Tiwari, Santosh
    Joshi, Parth
    Ferraris, Matias
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 900 - 907
  • [29] TREATMENT PATTERNS, HEALTH RESOURCES CONSUMPTION AND COSTS OF PATIENTS WITH MIGRAINE IN AN ITALIAN REAL-WORLD SETTING
    Perrone, V
    Veronesi, C.
    Andretta, M.
    Dell'Orco, S.
    De Sarro, G.
    Lena, F.
    Sonzogni, S.
    Naclerio, M.
    Ritrovato, D.
    Degli Esposti, L.
    VALUE IN HEALTH, 2019, 22 : S761 - S761
  • [30] Treatment patterns, health resource consumption, and costs of patients with migraine in an Italian real-world setting
    Perrone, Valentina
    Veronesi, Chiara
    Giacomini, Elisa
    Andretta, Margherita
    Dell'Orco, Stefania
    De Sarro, Giovambattista
    Lena, Fabio
    Menti, Anna Michela
    Naclerio, Mariantonietta
    Ritrovato, Daniela
    Degli Esposti, Luca
    CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (12) : 1991 - 1998
12345